Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials.
Almansour SA, Alqudah MAY, Abuhelwa Z, Al-Shamsi HO, Alhuraiji A, Semreen MH, Bustanji Y, Alzoubi KH, Modi ND, Mckinnon RA, Sorich MJ, Hopkins AM, Abuhelwa AY. Almansour SA, et al. Among authors: mckinnon ra. Ther Adv Med Oncol. 2024 Sep 2;16:17588359241275387. doi: 10.1177/17588359241275387. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39229471 Free PMC article.
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
Modi ND, Kichenadasse G, Hoffmann TC, Haseloff M, Logan JM, Veroniki AA, Venchiarutti RL, Smit AK, Tuffaha H, Jayasekara H, Manning-Bennet A, Morton E, McKinnon RA, Rowland A, Sorich MJ, Hopkins AM. Modi ND, et al. Among authors: mckinnon ra. BMC Med. 2023 Oct 23;21(1):400. doi: 10.1186/s12916-023-03113-0. BMC Med. 2023. PMID: 37872545 Free PMC article.
Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials.
Almansour SA, Alqudah MAY, Abuhelwa Z, Al-Shamsi HO, Semreen MH, Bustanji Y, Soare NC, McKinnon RA, Sorich MJ, Hopkins AM, Abuhelwa AY. Almansour SA, et al. Among authors: mckinnon ra. Sci Rep. 2024 Jan 5;14(1):591. doi: 10.1038/s41598-023-48640-1. Sci Rep. 2024. PMID: 38182614 Free PMC article. Clinical Trial.
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis.
Menz BD, Kuderer NM, Bacchi S, Modi ND, Chin-Yee B, Hu T, Rickard C, Haseloff M, Vitry A, McKinnon RA, Kichenadasse G, Rowland A, Sorich MJ, Hopkins AM. Menz BD, et al. Among authors: mckinnon ra. BMJ. 2024 Mar 20;384:e078538. doi: 10.1136/bmj-2023-078538. BMJ. 2024. PMID: 38508682 Free PMC article.
204 results